# US 2020/0138385 A1 · Systems and methods for dynamically and intelligently monitoring a host's glycemic condition after an alert is triggered

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0138385 A1
- Document ID: US20200138385A1
- Status: Published application
- Kind: A1
- Application number: 16/727,687
- Filed: 2019-12-26
- Published: 2020-05-07
- Earliest claimed: 2012-10-30
- Assignees: DexCom, Inc.
- Applicants: DexCom, Inc.
- Inventors: Hari Hampapuram; Anna Leigh Davis; Naresh C. Bhavaraju; Apurv Ullas Kamath; Claudio Cobelli; Giovanni Sparacino; Andrea Facchinetti; Chiara Zecchin
- Web page: https://patentgrep.com/patent/US20200138385A1

## CPC

- A61B 5/746: {Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms}
- A61B 5/0004: {characterised by the type of physiological signal transmitted}
- A61B 5/0022: {Monitoring a patient using a global network, e.g. telephone networks, internet}
- A61B 5/0031: {Implanted circuitry}
- A61B 5/14503: {invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors (A61B5/1459, A61B5/1464, A61B5/1473, A61B5/1482, A61B5/14865 take precedence)}
- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B 5/4848: {Monitoring or testing the effects of treatment, e.g. of medication}
- A61B 5/4866: {Evaluating metabolism (using breath test A61B5/083)}
- A61B 5/7221: {Determining signal validity, reliability or quality (preventing, reducing or removing noise induced by motion artefacts A61B5/7207; noise originating from a therapeutic or surgical apparatus A61B5/7217)}
- A61B 5/7275: {Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor}
- G16H 40/67: for remote operation
- G16H 50/30: for calculating health indices; for individual health risk assessment
- A61B 5/002: {Monitoring the patient using a local or closed circuit, e.g. in a room or building (A61B5/0017 takes precedence)}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

Systems and methods for providing sensitive and specific alarms indicative of glycemic condition are provided herein. In an embodiment, a method of processing sensor data by a continuous analyte sensor includes: evaluating sensor data using a first function to determine whether a real time glucose value meets a first threshold; evaluating sensor data using a second function to determine whether a predicted glucose value meets a second threshold; activating a hypoglycemic indicator if either the first threshold is met or if the second threshold is predicted to be met; and providing an output based on the activated hypoglycemic indicator.

## Claims

### Claim 1

A method of avoiding unnecessary hyperglycemic alerts, the method comprising:
initially activating a first alert state based on one or more first criteria associated with a hyperglycemic condition;
waiting a time period before providing an output associated with the first alert state;
actively monitoring, by a processor module, data associated with the host's hyperglycemic condition during the waiting time period; and
providing an output associated with the first alert state after the waiting time period based on the data associated with the host's hyperglycemic condition meeting one or more second criteria.

### Claim 2 (depends on 1)

The method of claim 1, wherein the actively monitoring comprises determining an average glucose over a window of time.

### Claim 3 (depends on 1)

The method of claim 1, wherein the actively monitoring comprises determining an amplitude and/or direction of rate of change.

### Claim 4 (depends on 1)

The method of claim 1, wherein the actively monitoring comprises determining an amplitude and/or direction of rate of acceleration.

### Claim 5 (depends on 1)

The method of claim 1, wherein the actively monitoring comprises evaluating insulin information.

### Claim 6 (depends on 1)

The method of claim 1, wherein the actively monitoring comprises evaluating meal information or timing.

### Claim 7 (depends on 1)

The method of claim 1, wherein the waiting time period is user selectable.

### Claim 8 (depends on 1)

The method of claim 1, further comprising not providing output associated with the first alert state after the waiting time period based on the data associated with the host's hyperglycemic condition not meeting the one or more second criteria.

### Claim 9 (depends on 1)

The method of claim 1, wherein the one or more first criteria and the one or more second criteria are the same.

### Claim 10 (depends on 1)

The method of claim 1, wherein the one or more first criteria and the one or more second criteria are different.

### Claim 11 (depends on 1)

The method of claim 1, further comprising transitioning from the first alert state to an inactive alert state based on the data associated with the host's hyperglycemic condition meeting one or more second criteria.

### Claim 12 (depends on 11)

The method of claim 11, wherein the one or more first criteria and the one or more second criteria are the same.

### Claim 13 (depends on 11)

The method of claim 11, wherein the one or more first criteria and the one or more second criteria are different.

### Claim 14

A system for processing data, the system comprising:
a continuous analyte sensor configured to be implanted within a body; and
sensor electronics configured to receive and process sensor data output by the sensor, the sensor electronics including a processor configured to:
initially activate a first alert state based on one or more first criteria associated with a hyperglycemic condition;
wait a time period before providing an output associated with the first alert state;
actively monitor data associated with the host's hyperglycemic condition during the waiting time period; and
provide an output associated with the first alert state after the waiting time period based on the data associated with the host's hyperglycemic condition meeting one or more second criteria.

### Claim 15 (depends on 14)

The system of claim 14, wherein the actively monitoring comprises determining an average glucose over a window of time.

### Claim 16 (depends on 14)

The system of claim 14, wherein the actively monitoring comprises determining an amplitude and/or direction of rate of change.

### Claim 17 (depends on 14)

The system of claim 14, wherein the actively monitoring comprises determining an amplitude and/or direction of rate of acceleration.
